Bioscreen is an Australian biotechnology company dedicated to the commercialisation of new diagnostic technology and the development on novel therapeutic agents. This WebSite is designed to provide remote access to the specialised Bioscreen testing services and associated information services. Further up-to-date information on research in chronic pain and fatigue disorders can be found at the The various tests and information are design to help medical practitioners arrive at an appropriate diagnosis for their patients, and the information obtained may lead to the design of effective management programs when administered by an appropriately informed physician. The WebSite represents an information base and an access route for ordering tests by practitioners and patients.
Looking for a particular Bioscreen employee's phone or email?
Bioscreen Questions
The Bioscreen annual revenue was $4 million in 2026.
Phillip Paull is the COO of Bioscreen.
4 people are employed at Bioscreen.
Bioscreen is based in Yarraville, Victoria.
The NAICS codes for Bioscreen are [5417, 541711, 54171, 54, 541].
The SIC codes for Bioscreen are [80, 283, 28].
Top Bioscreen Employees
-
Phillip Paull
Chief Operating Officer at Bioscreen
Altona, VIC, AU -
Henry Butt
Owner at Bioscreen
Melbourne, VIC, AU2
